[Clinical pharmacists in palliative care: effects on drug therapy and drug expenses]. / Apotheker auf der Palliativstation: Auswirkung auf Arzneimitteltherapie und Therapiekosten.
Schmerz
; 33(6): 533-538, 2019 Dec.
Article
em De
| MEDLINE
| ID: mdl-31463583
ABSTRACT
BACKGROUND:
The effect of integrating clinical pharmacists in German palliative care units with regard to the quality of drug therapy and drug costs has yet not been evaluated.OBJECTIVES:
This work aims to assess the number of pharmaceutical interventions (PI) and the cost-benefit ratio of a clinical pharmacist taking part in the interprofessional patient care team on an inpatient palliative care unit in Germany.METHODS:
The number of and underlying reasons for the pharmacist-led recommendations were recorded and analyzed over a 1-year period. In addition, the respective drugs and the acceptance rate of recommendations were assessed. To evaluate the cost-benefit ratio, the financial savings in the provision of drugs were recorded and compared with the expenses for the clinical pharmacy service.RESULTS:
A total of 245 PI were performed. Most frequently, the pharmacist advised physicians on drug choices and drug dosages. The acceptance rate was 93%. The cost savings in the provision of drugs covered 83% of the expenses for the clinical pharmacy service.CONCLUSION:
The results indicate that the integration of a clinical pharmacist is well suited to optimizing the interprofessional treatment of distressing symptoms with a beneficial economic outcome in palliative care. Consequently, the permanent integration of a clinical pharmacist on an inpatient palliative care unit seems to be beneficial and advisable.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cuidados Paliativos
/
Equipe de Assistência ao Paciente
/
Farmacêuticos
Tipo de estudo:
Guideline
/
Health_economic_evaluation
Limite:
Humans
País como assunto:
Europa
Idioma:
De
Ano de publicação:
2019
Tipo de documento:
Article